Transcriptome analysis revealed unique genes as targets for the anti-inflammatory action of activated protein C in human macrophages

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Pereira, Claudia P ^a   Bachli, Esther B ^b   Schaer, Dominik J ^a   Schoedon, Gabriele ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b Spital Uster   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ACYLTRANSFERASE; BINDING PROTEIN; CELL EXTRACT; CHROMATIN BINDING PROTEIN 4B; HISTONE ACETYLTRANSFERASE PCAF; TRANSCRIPTOME; UNCLASSIFIED DRUG; PRIMER DNA; PROTEIN C;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG TARGETING; ENZYME ACTIVITY; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; RNA ANALYSIS; TRANSCRIPTION REGULATION; GENE EXPRESSION PROFILING; METABOLISM; NUCLEOTIDE SEQUENCE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

BASE SEQUENCE; BLOTTING, WESTERN; DNA PRIMERS; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION; MACROPHAGES; PROTEIN C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 78149429237     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015352     Document Type: Article

References (41)

1. Charo IF, Ransohoff RM (2006) The Many Roles of Chemokines and Chemokine Receptors in Inflammation. N Engl J Med 354: 610-621.
2. Cohen J (2002) The immunopathogenesis of sepsis. Nature 420: 885-891.
3. Bernard GR, Vincent J-L, Laterre P-F, LaRosa SP, Dhainaut J-F, et al. (2001) Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis. N Engl J Med 344: 699-709.
4. Cavaillon JM A-CM (2005) Monocytes/macrophages and sepsis. Critical Care Medicine 33: S506-S509.
5. Toltl L, Swystun LL, Pepler L, Liaw P (2008) Protective effects of activated protein C in sepsis. Thrombosis and Haemostasis 100: 582-592.
6. Franscini N, Bachli EB, Blau N, Leikauf M-S, Schaffner A, et al. (2004) Gene Expression Profiling of Inflamed Human Endothelial Cells and Influence of Activated Protein C. Circulation 110: 2903-2909.
7. Vincent J, Bernard G, Beale R, Doig C, Putensen C, et al. (2005) Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: further evidence for survival and safety and implications for early treatment. Critical Care Medicine 33: 2266-2277.
8. Rezaie AR (2010) Regulation of the Protein C Anticoagulant and Antiinflammatory Pathways. Curr Med Chem 17: 2059-2069.
9. Marino F, Pelc LA, Vogt A, Gandhi PS, Di Cera E (2010) Engineering Thrombin for Selective Specificity toward Protein C and PAR1. Journal of Biological Chemistry 285: 19145-19152.
10. Weiler H (2010) Regulation of inflammation by the protein C system. Critical Care Medicine 38: S18-S25. 10.1097/CCM.1090b1013e3181c1099cbb1095.
11. Pereira C, Bachli EB, Schoedon G (2007) Transcriptome analysis of the PAR-1 mediated activation pathway in human monocytes and interactions of Activated Protein C. J Thromb Haemost 5: P-M-090.
12. Pereira C, Schaer DJ, Bachli EB, Kurrer MO, Schoedon G (2008) Wnt5A/CaMKII Signaling Contributes to the Inflammatory Response of Macrophages and Is a Target for the Antiinflammatory Action of Activated Protein C and Interleukin-10. Arterioscler Thromb Vasc Biol 28: 504-510.
13. Ehrchen J, Steinmuller L, Barczyk K, Tenbrock K, Nacken W, et al. (2007) Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood 109: 1265-1274.
14. Stephenson DA, Toltl LJ, Beaudin S, Liaw PC (2006) Modulation of Monocyte Function by Activated Protein C, a Natural Anticoagulant. J Immunol 177: 2115-2122.
15. White B, Schmidt M, Murphy C, Livingstone W, O'Toole D, et al. (2000) Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kB and tumour necrosis factor alpha1 production in the THP-1 monocytic cell line. British Journal of Haematology 110: 130-134.
16. Breeden L, Nasmyth K (1987) Similarity of cell-cycle genes of budding yeast and fission yeast and the Notch gene in Drosophila. Nature 395: 651-654.
17. Michaely P, Bennett V (1993) The membrane-binding domain of ankyrin contains four independently folded subdomains, each comprised of six ankyrin repeats. J Biol Chem 268: 22703-22709.
18. Bork P (1993) Hundreds of ankyrin-like repeats in functionally diverse proteins: mobile modules that cross phyla horizontally. Proteins 17: 363-374.
19. Groves M, Barford D (1999) Topological characteristics of helical repeat proteins. Current Opinion Structural Biology 9: 383-389.
20. Brown K, Arthur J (2001) Selenium, selenoproteins and human health: a review. Public Health Nutrition 4: 593-599.
21. Dreher I, Jakobs TC, Kohrle J (1997) Cloning and Characterization of the Human Selenoprotein P Promoter. Response of Selenoprotein P Expression to Cytokynes in Liver Cells. J Biol Chem 272: 29364-29371.
22. Mostert V, Dreher I, Köhrle J, Wolff S, Abel J (2001) Modulation of selenoprotein P expression by TGF-beta 1 is mediated by Smad proteins Biofactors 14: 135-142.
23. Hassanzadeh Ghassabeh G, De Baetselier P, Brys L, Noel W, Van Ginderachter JA, et al. (2006) Identification of a common gene signature for type II cytokine-associated myeloid cells elicited in vivo in different pathologic conditions. Blood 108: 575-583.
24. Lehrke M, Lazar MA (2004) Inflamed about obesity. Nat Med 10: 126-127.
25. White B, Schmidt M, Murphy C, Livingstone W, O'Toole D, et al. (2000) Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kappaB (NF-kappaB) and tumour necrosis factor alpha (TNFalpha) production in the THP-1 monocytic cell line. Br J Haematol 110: 130-134.
26. Yuksel M, Okajima K, Uchiba M, Horiuchi S, Okabe H (2002) Activated protein C inhibits lipopolysaccharide-induced tumor necrosis factor-alpha production by inhibiting activation of both nuclear factor-kappa B and activator protein-1 in human monocytes. Thrombosis and haemostasis 88: 267-273.
27. Kipling D, Warburton PE (1997) Centromeres, CENP-B and Tigger too. Trends in Genetics 13: 141-145.
28. Lee K-Y, Ito K, Hayashi R, Jazrawi EPI, Barnes PJ, et al. (2006) NF-{kappa}B and Activator Protein 1 Response Elements and the Role of Histone Modifications in IL-1{beta}-Induced TGF-{beta}1 Gene Transcription. J Immunol 176: 603-615.
29. Ito K, Barnes PJ, Adcock IM (2000) Glucocorticoid Receptor Recruitment of Histone Deacetylase 2 Inhibits Interleukin-1beta -Induced Histone H4 Acetylation on Lysines 8 and 12. Mol Cell Biol 20: 6891-6903.
30. Keslacy S, Tliba O, Baidouri H, Amrani Y (2007) Inhibition of Tumor Necrosis Factor-{alpha}-Inducible Inflammatory Genes by Interferon-{gamma} Is Associated with Altered Nuclear Factor-{kappa}B Transactivation and Enhanced Histone Deacetylase Activity. Mol Pharmacol 71: 609-618.
31. Schmeck B, Lorenz J, N'Guessan PD, Opitz B, van Laak V, et al. (2008) Histone Acetylation and Flagellin Are Essential for Legionella pneumophila-Induced Cytokine Expression. J Immunol 181: 940-947.
32. Reddy P, Sun Y, Toubai T, Duran-Struuck R, Clouthier SG, et al. (2008) Histone deacetylase inhibition modulates indoleamine 2,3-dioxygenase-dependent DC functions and regulates experimental graft-versus-host disease in mice. J Clin Invest 118: 2562-2573.
33. Leoni F, Zaliani A, Bertolini G, Porro G, Pagani P, et al. (2002) The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines. PNAS 99: 2995-3000.
34. Schmeck B, Beermann W, N'Guessan PD, Hocke AC, Opitz B, et al. (2008) Simvastatin Reduces Chlamydophila pneumoniae-Mediated Histone Modifications and Gene Expression in Cultured Human Endothelial Cells. Circ Res 102: 888-895.
35. Bode KA, Schroder K, Hume DA, Ravasi T, Heeg K, et al. (2007) Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment. Immunology 122: 596-606.
36. Gabellini D, Colaluca IN, Vodermaier HC, Biamonti G, Giacca M, et al. (2003) Early mitotic degradation of the homeoprotein HOXC10 is potentially linked to cell cycle progression. EMBO 22: 3715-3724.
37. Cillo C, Cantile M, Faiella A, Boncinelli E (2001) Homeobox genes in normal and malignant cells. Journal of Cellular Physiology 188: 161-169.
38. Abate-Shen C (2002) Deregulated homeobox gene expression in cancer: cause or consequence? Nat Rev Cancer 2: 777-785.
39. Chen XP, Losman JA, Rothman P (2000) SOCS Proteins, Regulators of Intracellular Signaling. Immunity 13: 287-290.
40. Martens N, Wery M, Wang P, Braet F, Gertler A, et al. (2004) The suppressor of cytokine signaling (SOCS)-7 interacts with the actin cytoskeleton through vinexin. Experimental Cell Research 298: 239-248.
41. Akamatsu M, Aota S-i, Suwa A, Ueda K, Amachi T, et al. (1999) Vinexin Forms a Signaling Complex with Sos and Modulates Epidermal Growth Factorinduced c-Jun N-terminal Kinase/Stress-activated Protein Kinase Activities. J Biol Chem 274: 35933-35937.